Ascent Group’s Wave Life Sciences WVE Stock Holding History

Ascent Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,237	Closed	-$82.7K	–	774
2025 Q1	$82.7K	Buy	+10,237	New	+$112K	﹤0.01%	688

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ascent Group's WVE Position: Q2 2025 in Review

Ascent Group sold out of Wave Life Sciences (WVE) in Q2 2025, closing a stake of 10,237 shares — an estimated $82.7K sold.

Ascent Group first reported a position in WVE in Q1 2025 and held it in 1 quarter. The position peaked at $82.7K in Q1 2025. 176 funds tracked by Wall St. Rank hold WVE as of Q2 2025.

Ascent Group reported no remaining Wave Life Sciences position as of Q2 2025 after selling out during the quarter.
Ascent Group sold 10,237 Wave Life Sciences shares in Q2 2025, an estimated $82.7K.
Ascent Group first reported a position in Wave Life Sciences in Q1 2025 and held it in 1 quarter.
Ascent Group's Wave Life Sciences position peaked at $82.7K in Q1 2025.
176 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2025.

Based on Ascent Group's 13F filing for Q2 2025, filed 21 Jul 2025.